Announcement on Obtaining Drug Registration Certificate for Levosalbutamol Hydrochloride Nebuliser Solution
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining Drug Registration Certificate for Levosalbutamol Hydrochloride Nebuliser Solution
Filed with SSE · · 2 pages · Chinese
Release
Hunan Nucien Pharmaceutical Co. Ltd. on 6ix
Earlier from Hunan Nucien Pharmaceutical
- Announcement on Voluntary Disclosure of Phase III Clinical Trial of Peramivir Inhalation Solution Reaching Prespecified Primary Endpoint
- Announcement on Receiving the Prior Notice of Administrative Penalty
- Announcement on Progress in Transfer of Partial Accounts Receivable and Related Party Transactions
- Announcement on Resolutions of the 2025 Annual General Meeting
- Indicative Announcement on the Controlling Shareholder's Planning of Strategic Restructuring
Later from Hunan Nucien Pharmaceutical
- Announcement on Progress in the Strategic Restructuring of Controlling Shareholders
- Announcement on Receipt of Drug Registration Acceptance Notice
- Announcement on Implementing Cancellation of Repurchased Shares and Share Changes
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report
Follow Hunan Nucien Pharmaceutical into a list and get an email when it puts out news.
Follow Hunan Nucien Pharmaceutical